AI In Pathology Market Size, Share, Trends, Industry Analysis Report By Offering, By Neural Network, By Function, By Use Case, By End User, By Region – Market Forecast, 2025–2034
Description
The AI in Pathology market size is expected to reach USD 113.02 Billion by 2034, according to a new study by Polaris Market Research. The report “AI In Pathology Market Size, Share, Trends, Industry Analysis Report By Offering, By Neural Network, By Function, By Use Case, By End User, By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The AI in Pathology market is witnessing strong growth driven by the rising prevalence of cancer and chronic diseases, the growing adoption of digital pathology, and increasing demand for accurate and efficient diagnostic solutions.
Advancements in deep learning, computer vision, and image analysis are accelerating diagnostic workflows and improving precision in disease detection. Leading players are focusing on developing scalable and interoperable AI-driven pathology platforms that enhance diagnostic accuracy, support personalized medicine, and meet global healthcare innovation and digital transformation goals.
AI In Pathology Market Report Highlights
Based on offering, the end-to-end solutions segment dominated the market in 2024, driven by their ability to provide comprehensive support across the entire pathology workflow from image acquisition to diagnostics and reporting.
In terms of neural network type, the convolutional neural networks (CNN) segment held the largest share in 2024, owing to their proven accuracy in image recognition, segmentation, and classification tasks within digital pathology.
By function, the image analysis segment led the market in 2024, fueled by growing adoption of AI tools to automate routine pathology tasks, minimize diagnostic errors, and improve laboratory throughput.
Based on use case, the disease diagnosis and prognosis segment accounted for the largest share in 2024, supported by increasing demand for early and precise detection of cancer, infectious diseases, and chronic disorders.
In terms of end user, the hospitals and reference laboratories segment dominated the market in 2024, driven by rapid implementation of AI-assisted digital pathology systems for both routine and complex diagnostic workflows.
North America accounted for a significant share in 2024, supported by strong integration of digital pathology and AI-based diagnostic tools across healthcare and research institutions.
The Asia Pacific market grew rapidly in 2024, fueled by expanding healthcare digitalization, increasing investments in AI infrastructure, and growing adoption of AI-driven pathology solutions across emerging economies.
A few key global players include Aiforia Technologies Plc, Akoya Biosciences, Inc., Deep Bio Inc., Hologic, Inc., Ibex Medical Analytics Ltd., Indica Labs Inc., Koninklijke Philips N.V., Mindpeak GmbH, OptraScan, Inc., Paige AI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, and Visiopharm A/S.
Polaris Market Research has segmented the market report on the basis of offering, neural network, function, use case, end user, and region:
By Offering Outlook (Revenue, USD Billion, 2020–2034)
End-to-End Solutions
Niche Point Solutions
Technology
Hardware
Microscopes
Scanners
Storage Systems
By Neural Network Outlook (Revenue, USD Billion, 2020–2034)
Convolutional Neural Networks (CNNS)
Generative Adversarial Networks (GANS)
Recurrent Neural Networks (RNNS)
Other Neural Networks
By Function Outlook (Revenue, USD Billion, 2020–2034)
Image Analysis
Diagnostics
Workflow Management
Data Management
Predictive Analytics
CDSS
Automated Report Generation
Quality Assurance Tools
By Use Case Outlook (Revenue, USD Billion, 2020–2034)
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End User Outlook (Revenue, USD Billion, 2020–2034)
Pharmaceutical & Biopharmaceutical Companies
Hospitals & Reference Laboratories
Academic & Research Institutes
By Regional Outlook (Revenue, USD Billion, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
The AI in Pathology market is witnessing strong growth driven by the rising prevalence of cancer and chronic diseases, the growing adoption of digital pathology, and increasing demand for accurate and efficient diagnostic solutions.
Advancements in deep learning, computer vision, and image analysis are accelerating diagnostic workflows and improving precision in disease detection. Leading players are focusing on developing scalable and interoperable AI-driven pathology platforms that enhance diagnostic accuracy, support personalized medicine, and meet global healthcare innovation and digital transformation goals.
AI In Pathology Market Report Highlights
Based on offering, the end-to-end solutions segment dominated the market in 2024, driven by their ability to provide comprehensive support across the entire pathology workflow from image acquisition to diagnostics and reporting.
In terms of neural network type, the convolutional neural networks (CNN) segment held the largest share in 2024, owing to their proven accuracy in image recognition, segmentation, and classification tasks within digital pathology.
By function, the image analysis segment led the market in 2024, fueled by growing adoption of AI tools to automate routine pathology tasks, minimize diagnostic errors, and improve laboratory throughput.
Based on use case, the disease diagnosis and prognosis segment accounted for the largest share in 2024, supported by increasing demand for early and precise detection of cancer, infectious diseases, and chronic disorders.
In terms of end user, the hospitals and reference laboratories segment dominated the market in 2024, driven by rapid implementation of AI-assisted digital pathology systems for both routine and complex diagnostic workflows.
North America accounted for a significant share in 2024, supported by strong integration of digital pathology and AI-based diagnostic tools across healthcare and research institutions.
The Asia Pacific market grew rapidly in 2024, fueled by expanding healthcare digitalization, increasing investments in AI infrastructure, and growing adoption of AI-driven pathology solutions across emerging economies.
A few key global players include Aiforia Technologies Plc, Akoya Biosciences, Inc., Deep Bio Inc., Hologic, Inc., Ibex Medical Analytics Ltd., Indica Labs Inc., Koninklijke Philips N.V., Mindpeak GmbH, OptraScan, Inc., Paige AI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, and Visiopharm A/S.
Polaris Market Research has segmented the market report on the basis of offering, neural network, function, use case, end user, and region:
By Offering Outlook (Revenue, USD Billion, 2020–2034)
End-to-End Solutions
Niche Point Solutions
Technology
Hardware
Microscopes
Scanners
Storage Systems
By Neural Network Outlook (Revenue, USD Billion, 2020–2034)
Convolutional Neural Networks (CNNS)
Generative Adversarial Networks (GANS)
Recurrent Neural Networks (RNNS)
Other Neural Networks
By Function Outlook (Revenue, USD Billion, 2020–2034)
Image Analysis
Diagnostics
Workflow Management
Data Management
Predictive Analytics
CDSS
Automated Report Generation
Quality Assurance Tools
By Use Case Outlook (Revenue, USD Billion, 2020–2034)
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End User Outlook (Revenue, USD Billion, 2020–2034)
Pharmaceutical & Biopharmaceutical Companies
Hospitals & Reference Laboratories
Academic & Research Institutes
By Regional Outlook (Revenue, USD Billion, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. AI In Pathology Market Insights
- 4.1. AI In Pathology Market – Market Snapshot
- 4.2. AI In Pathology Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Cancer and Chronic Diseases
- 4.2.1.2. Increasing R&D Investments in Biomarker Discovery
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Implementation Costs
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. AI In Pathology Market Trends
- 4.6. Value Chain Analysis
- 5. AI In Pathology Market, by Offering
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 5.3. End-To-End Solutions
- 5.3.1. AI In Pathology Market, by End-To-End Solutions, by Region, 2020-2034 (USD Billion)
- 5.4. Niche Point Solutions
- 5.4.1. AI In Pathology Market, by Niche Point Solutions, 2020-2034 (USD Billion)
- 5.5. Technology
- 5.5.1. AI In Pathology Market, by Technology, by Region, 2020-2034 (USD Billion)
- 5.6. Hardware
- 5.6.1. AI In Pathology Market, by Hardware, by Region, 2020-2034 (USD Billion)
- 5.7. Microscopes
- 5.7.1. AI In Pathology Market, by Microscopes, by Region, 2020-2034 (USD Billion)
- 5.8. Scanners
- 5.8.1. AI In Pathology Market, by Scanners, by Region, 2020-2034 (USD Billion)
- 5.9. Storage Systems
- 5.9.1. AI In Pathology Market, by Storage Systems, by Region, 2020-2034 (USD Billion)
- 6. AI In Pathology Market, by Neural Network
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 6.3. Convolutional Neural Networks (CNNS)
- 6.3.1. AI In Pathology Market, by Convolutional Neural Networks (CNNS), by Region, 2020-2034 (USD Billion)
- 6.4. Generative Adversarial Networks (GANS)
- 6.4.1. AI In Pathology Market, by Generative Adversarial Networks (GANS), by Region, 2020-2034 (USD Billion)
- 6.5. Recurrent Neural Networks (RNNS)
- 6.5.1. AI In Pathology Market, by Recurrent Neural Networks (RNNS), by Region, 2020-2034 (USD Billion)
- 6.6. Other Neural Networks
- 6.6.1. AI In Pathology Market, by Other Neural Networks, by Region, 2020-2034 (USD Billion)
- 7. AI In Pathology Market, by Function
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 7.3. Image Analysis
- 7.3.1. AI In Pathology Market, by Image Analysis, by Region, 2020-2034 (USD Billion)
- 7.4. Diagnostics
- 7.4.1. AI In Pathology Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
- 7.5. Workflow Management
- 7.5.1. AI In Pathology Market, by Workflow Management, by Region, 2020-2034 (USD Billion)
- 7.6. Data Management
- 7.6.1. AI In Pathology Market, by Data Management, by Region, 2020-2034 (USD Billion)
- 7.7. Predictive Analytics
- 7.7.1. AI In Pathology Market, by Predictive Analytics, by Region, 2020-2034 (USD Billion)
- 7.8. CDSS
- 7.8.1. AI In Pathology Market, by CDSS, by Region, 2020-2034 (USD Billion)
- 7.9. Automated Report Generation
- 7.9.1. AI In Pathology Market, by Automated Report Generation, by Region, 2020-2034 (USD Billion)
- 7.10. Quality Assurance Tools
- 7.10.1. AI In Pathology Market, by Quality Assurance Tools, by Region, 2020-2034 (USD Billion)
- 8. AI In Pathology Market, by Use Case
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 8.3. Drug Discovery
- 8.3.1. AI In Pathology Market, by Drug Discovery, by Region, 2020-2034 (USD Billion)
- 8.4. Disease Diagnosis & Prognosis
- 8.4.1. AI In Pathology Market, by Disease Diagnosis & Prognosis, by Region, 2020-2034 (USD Billion)
- 8.5. Clinical Workflow
- 8.5.1. AI In Pathology Market, by Clinical Workflow, by Region, 2020-2034 (USD Billion)
- 8.6. Training & Education
- 8.6.1. AI In Pathology Market, by Training & Education, by Region, 2020-2034 (USD Billion)
- 9. AI In Pathology Market, by End User
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 9.3. Pharmaceutical & Biopharmaceutical Companies
- 9.3.1. AI In Pathology Market, by Pharmaceutical & Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
- 9.4. Hospitals & Reference Laboratories
- 9.4.1. AI In Pathology Market, by Hospitals & Reference Laboratories, by Region, 2020-2034 (USD Billion)
- 9.5. Academic & Research Institutes
- 9.5.1. AI In Pathology Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)
- 10. AI In Pathology Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. AI In Pathology Market Assessment, By Geography, 2020-2034 (USD Billion)
- 10.3. AI In Pathology Market – North America
- 10.3.1. North America: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.3.2. North America: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.3.3. North America: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.3.4. North America: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.3.5. North America: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.3.6. AI In Pathology Market – U.S.
- 10.3.6.1. U.S.: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.3.6.2. U.S.: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.3.6.3. U.S.: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.3.6.4. U.S.: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.3.6.5. U.S.: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.3.7. AI In Pathology Market – Canada
- 10.3.7.1. Canada: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.3.7.2. Canada: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.3.7.3. Canada: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.3.7.4. Canada: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.3.7.5. Canada: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4. AI In Pathology Market – Europe
- 10.4.1. Europe: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.2. Europe: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.3. Europe: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.4. Europe: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.5. Europe: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4.6. AI In Pathology Market – UK
- 10.4.6.1. UK: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.6.2. UK: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.6.3. UK: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.6.4. UK: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.6.5. UK: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4.7. AI In Pathology Market – France
- 10.4.7.1. France: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.7.2. France: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.7.3. France: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.7.4. France: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.7.5. France: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4.8. AI In Pathology Market – Germany
- 10.4.8.1. Germany: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.8.2. Germany: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.8.3. Germany: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.8.4. Germany: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.8.5. Germany: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4.9. AI In Pathology Market – Italy
- 10.4.9.1. Italy: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.9.2. Italy: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.9.3. Italy: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.9.4. Italy: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.9.5. Italy: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4.10. AI In Pathology Market – Spain
- 10.4.10.1. Spain: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.10.2. Spain: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.10.3. Spain: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.10.4. Spain: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.10.5. Spain: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4.11. AI In Pathology Market – Netherlands
- 10.4.11.1. Netherlands: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.11.2. Netherlands: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.11.3. Netherlands: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.11.4. Netherlands: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.11.5. Netherlands: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4.12. AI In Pathology Market – Russia
- 10.4.12.1. Russia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.12.2. Russia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.12.3. Russia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.12.4. Russia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.12.5. Russia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.4.13. AI In Pathology Market – Rest of Europe
- 10.4.13.1. Rest of Europe: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.4.13.2. Rest of Europe: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.4.13.3. Rest of Europe: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.4.13.4. Rest of Europe: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.4.13.5. Rest of Europe: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5. AI In Pathology Market – Asia Pacific
- 10.5.1. Asia Pacific: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5.6. AI In Pathology Market – China
- 10.5.6.1. China: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.6.2. China: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.6.3. China: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.6.4. China: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.6.5. China: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5.7. AI In Pathology Market – India
- 10.5.7.1. India: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.7.2. India: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.7.3. India: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.7.4. India: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.7.5. India: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5.8. AI In Pathology Market – Malaysia
- 10.5.8.1. Malaysia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.8.2. Malaysia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.8.3. Malaysia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.8.4. Malaysia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.8.5. Malaysia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5.9. AI In Pathology Market – Japan
- 10.5.9.1. Japan: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.9.2. Japan: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.9.3. Japan: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.9.4. Japan: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.9.5. Japan: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5.10. AI In Pathology Market – Indonesia
- 10.5.10.1. Indonesia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.10.2. Indonesia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.10.3. Indonesia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.10.4. Indonesia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.10.5. Indonesia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5.11. AI In Pathology Market – South Korea
- 10.5.11.1. South Korea: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.11.2. South Korea: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.11.3. South Korea: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.11.4. South Korea: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.11.5. South Korea: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5.12. AI In Pathology Market – Australia
- 10.5.12.1. Australia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.12.2. Australia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.12.3. Australia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.12.4. Australia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.12.5. Australia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.5.13. AI In Pathology Market – Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.5.13.2. Rest of Asia Pacific: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.5.13.3. Rest of Asia Pacific: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.5.13.4. Rest of Asia Pacific: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.5.13.5. Rest of Asia Pacific: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.6. AI In Pathology Market – Middle East & Africa
- 10.6.1. Middle East & Africa: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.6.6. AI In Pathology Market – Saudi Arabia
- 10.6.6.1. Saudi Arabia: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.6.6.2. Saudi Arabia: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.6.6.3. Saudi Arabia: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.6.6.4. Saudi Arabia: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.6.6.5. Saudi Arabia: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.6.7. AI In Pathology Market – UAE
- 10.6.7.1. UAE: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.6.7.2. UAE: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.6.7.3. UAE: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.6.7.4. UAE: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.6.7.5. UAE: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.6.8. AI In Pathology Market – Israel
- 10.6.8.1. Israel: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.6.8.2. Israel: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.6.8.3. Israel: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.6.8.4. Israel: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.6.8.5. Israel: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.6.9. AI In Pathology Market – South Africa
- 10.6.9.1. South Africa: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.6.9.2. South Africa: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.6.9.3. South Africa: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.6.9.4. South Africa: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.6.9.5. South Africa: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.6.10. AI In Pathology Market – Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.6.10.2. Rest of Middle East & Africa: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.6.10.3. Rest of Middle East & Africa: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.6.10.4. Rest of Middle East & Africa: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.6.10.5. Rest of Middle East & Africa: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.7. AI In Pathology Market – Latin America
- 10.7.1. Latin America: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.7.2. Latin America: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.7.3. Latin America: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.7.4. Latin America: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.7.5. Latin America: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.7.6. AI In Pathology Market – Mexico
- 10.7.6.1. Mexico: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.7.6.2. Mexico: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.7.6.3. Mexico: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.7.6.4. Mexico: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.7.6.5. Mexico: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.7.7. AI In Pathology Market – Brazil
- 10.7.7.1. Brazil: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.7.7.2. Brazil: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.7.7.3. Brazil: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.7.7.4. Brazil: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.7.7.5. Brazil: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.7.8. AI In Pathology Market – Argentina
- 10.7.8.1. Argentina: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.7.8.2. Argentina: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.7.8.3. Argentina: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.7.8.4. Argentina: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.7.8.5. Argentina: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 10.7.9. AI In Pathology Market – Rest of Latin America
- 10.7.9.1. Rest of Latin America: AI In Pathology Market, by Offering, 2020-2034 (USD Billion)
- 10.7.9.2. Rest of Latin America: AI In Pathology Market, by Neural Network, 2020-2034 (USD Billion)
- 10.7.9.3. Rest of Latin America: AI In Pathology Market, by Function, 2020-2034 (USD Billion)
- 10.7.9.4. Rest of Latin America: AI In Pathology Market, by Use Case, 2020-2034 (USD Billion)
- 10.7.9.5. Rest of Latin America: AI In Pathology Market, by End User, 2020-2034 (USD Billion)
- 11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
- 12. Company Profiles
- 12.1. Aiforia Technologies Plc
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Akoya Biosciences, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Deep Bio Inc.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Hologic, Inc.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Ibex Medical Analytics Ltd.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Indica Labs Inc.
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Koninklijke Philips N.V.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Mindpeak GmbH
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. OptraScan, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Paige AI, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Proscia Inc.
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Techcyte, Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


